title: Intracellular energetics and critical PO2 in resting ischemic human skeletal muscle in vivo.
abstract: During ischemia and some types of muscular contractions, oxygen tension (Po(2)) declines to the point that mitochondrial ATP synthesis becomes limited by oxygen availability. Although this critical Po(2) has been determined in animal tissue in vitro and in situ, there remains controversy concerning potential disparities between values measured in vivo and ex vivo. To address this issue, we used concurrent heteronuclear magnetic resonance spectroscopy (MRS) to determine the critical intracellular Po(2) in resting human skeletal muscle in vivo. We interleaved measurements of deoxymyoglobin using (1)H-MRS with measures of high-energy phosphates and pH using (31)P-MRS, during 15 min of ischemia in the tibialis anterior muscles of 6 young men. ATP production and intramyocellular Po(2) were quantified throughout ischemia. Critical Po(2), determined as the Po(2) corresponding to the point where PCr begins to decline (PCr(ip)) in resting muscle during ischemia, was 0.35 ± 0.20 Torr, means ± SD. This in vivo value is consistent with reported values ex vivo and does not support the notion that critical Po(2) in resting muscle is higher when measured in vivo. Furthermore, we observed a 4.5-fold range of critical Po(2) values among the individuals studied. Regression analyses revealed that time to PCr(ip) was associated with critical Po(2) and the rate of myoglobin desaturation (r = 0.83, P = 0.04) but not the rate of ATP consumption during ischemia. The apparent dissociation between ATP demand and myoglobin deoxygenation during ischemia suggests that some degree of uncoupling between intracellular energetics and oxygenation is a potentially important factor that influences critical Po(2) in vivo.
authors.affiliation: Kinesiology Department, University of Massachusetts, Amherst Massachusetts 01003, USA.
authors.forename: Ian R
authors.initials: IR
authors.lastname: Lanza
authors.forename: Michael A
authors.initials: MA
authors.lastname: Tevald
authors.forename: Douglas E
authors.initials: DE
authors.lastname: Befroy
authors.forename: Jane A
authors.initials: JA
authors.lastname: Kent-Braun
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000328:Adult; D004734:Energy Metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007511:Ischemia / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008931:Mitochondria, Muscle; D018482:Muscle, Skeletal / Q000098:blood supply / Q000378:metabolism*; D009211:Myoglobin / Q000378:metabolism; D010085:Oxidative Phosphorylation; D010100:Oxygen / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism; D012146:Rest; D013997:Time Factors
chemical_list: D009211:Myoglobin; C055547:deoxymyoglobin; D010725:Phosphocreatine; D000255:Adenosine Triphosphate; D010100:Oxygen
references.citation: Acta Physiol Scand. 2000 Apr;168(4):609-14
references.pmid: 10759597
references.citation: Am J Physiol. 1997 Sep;273(3 Pt 1):C852-8
references.pmid: 9316405
references.citation: Am J Physiol. 1974 Jan;226(1):173-7
references.pmid: 4809879
references.citation: J Appl Physiol (1985). 2004 Dec;97(6):2385-94
references.pmid: 15298991
references.citation: J Physiol. 1941 Mar 25;99(3):283-303
references.pmid: 16995251
references.citation: Biochem J. 1993 May 1;291 ( Pt 3):681-6
references.pmid: 8489495
references.citation: Am J Physiol. 1999 Mar;276(3):C692-9
references.pmid: 10069997
references.citation: J Biol Chem. 1990 Sep 15;265(26):15392-402
references.pmid: 2394731
references.citation: Am J Physiol. 1964 Apr;206:858-66
references.pmid: 14166185
references.citation: Am J Physiol. 1986 Oct;251(4 Pt 2):H789-99
references.pmid: 3766756
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1057-62
references.pmid: 17215370
references.citation: J Appl Physiol (1985). 1996 Sep;81(3):1410-7
references.pmid: 8889781
references.citation: Scand J Clin Lab Invest. 1975 Jan;35(1):87-95
references.pmid: 1129596
references.citation: J Appl Physiol (1985). 1990 Mar;68(3):833-42
references.pmid: 2187852
references.citation: Nature. 1974 Nov 22;252(5481):285-7
references.pmid: 4431445
references.citation: Scand J Clin Lab Invest. 1974 Apr;33(2):109-20
references.pmid: 4852173
references.citation: Magn Reson Q. 1994 Mar;10(1):43-63
references.pmid: 8161485
references.citation: Am J Physiol. 1986 Mar;250(3 Pt 1):C384-90
references.pmid: 3006503
references.citation: Arch Biochem Biophys. 1978 Nov;191(1):8-22
references.pmid: 736575
references.citation: Am J Physiol. 1999 Nov;277(5):H1831-40
references.pmid: 10564137
references.citation: J Physiol. 2006 Mar 1;571(Pt 2):415-24
references.pmid: 16396926
references.citation: Am J Physiol Endocrinol Metab. 2002 Jan;282(1):E74-9
references.pmid: 11739086
references.citation: Am J Physiol. 1995 Oct;269(4 Pt 2):H1328-41
references.pmid: 7485565
references.citation: Magn Reson Med. 1997 Nov;38(5):834-9
references.pmid: 9358459
references.citation: Am J Physiol. 1987 May;252(5 Pt 2):H906-15
references.pmid: 3578540
references.citation: Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):11080-5
references.pmid: 11005877
references.citation: Eur J Appl Physiol. 2009 Jun;106(3):333-43
references.pmid: 19277696
references.citation: Am J Physiol. 1997 Nov;273(5):C1613-22
references.pmid: 9374647
references.citation: J Physiol. 2006 Nov 15;577(Pt 1):353-67
references.pmid: 16945975
references.citation: Am J Physiol Heart Circ Physiol. 2003 Nov;285(5):H1900-8
references.pmid: 12775561
references.citation: J Physiol. 1993 Jun;465:203-22
references.pmid: 8024651
references.citation: J Appl Physiol (1985). 1997 Jan;82(1):86-92
references.pmid: 9029202
references.citation: Arch Biochem Biophys. 1979 Jul;195(2):494-504
references.pmid: 224820